Who
Charles Brynelsen
Director
Company insider
Files Form 4 as: Director, Envoy Medical; Senior Vice President, Abbott Laboratories.
In numbers
- Trades disclosed
- 30
- Buys
- 4
- Sells
- 3
- Bought
- $882K
- Sold
- $338K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 24 Jul 2017
- Last trade
- 12 Feb 2026
- Last filed
- 17 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $400K1,000,000 at $0.40 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —600,000 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —1,000,000 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —600,000 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —1,000,000 at $0.00 | filing |
| 12 Feb 2026filed 17 Feb 2026 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $400K1,000,000 at $0.40 | filing |
| 3 Dec 2025filed 5 Dec 2025 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 27 May 2025filed 27 May 2025 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $58K35,000 at $1.65 | filing |
| 23 May 2025filed 27 May 2025 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $21K13,000 at $1.64 | filing |
| 22 May 2025filed 27 May 2025 | COCH Envoy MedicalMedical Devices | SEC FORM 4 Bought | $3,3602,000 at $1.68 | filing |
| 15 Oct 2023filed 17 Oct 2023 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 1 Mar 2021filed 2 Mar 2021 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $121K1,002 at $120.61 | filing |
| 26 Feb 2021filed 2 Mar 2021 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $858K7,060 at $121.58 | filing |
| 19 Feb 2021filed 23 Feb 2021 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,994 at $0.00 | filing |
| 19 Feb 2021filed 23 Feb 2021 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —7,802 at $0.00 | filing |
| 24 Jul 2020filed 28 Jul 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $166K1,650 at $100.82 | filing |
| 2 Mar 2020filed 3 Mar 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $139K1,781 at $77.89 | filing |
| 28 Feb 2020filed 3 Mar 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $374K4,720 at $79.19 | filing |
| 21 Feb 2020filed 25 Feb 2020 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 21 Feb 2020filed 25 Feb 2020 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,198 at $0.00 | filing |
News
DENTSPLY SIRONA (NASDAQ:XRAY) & Envoy Medical (NASDAQ:COCH) Financial AnalysisCOCH · tickerreport.com · 19 Oct 2026Contrasting Biomerica (NASDAQ:BMRA) and Envoy Medical (NASDAQ:COCH)COCH · themarketsdaily.com · 19 Oct 2026Financial Survey: RxSight (NASDAQ:RXST) versus Envoy Medical (NASDAQ:COCH)COCH · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Charles Brynelsen; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.